Skip to main content
. 2024 May 31;14:12559. doi: 10.1038/s41598-024-63337-9

Figure 3.

Figure 3

Comparison of virus-neutralizing antibody titers against HEP, HEP-10V and HEP-30V using vaccinated rabbit sera. Sera were collected from each of four rabbits (H1, H2, A1, A2). H1 and H2 were inoculated with the human-RABV vaccine (Rabipur, GSK Biologicals, Wavre, Belgium) and A1 and A2 were inoculated with the animal-RABV vaccine (KMB, KM Biologics, Kumamoto, Japan). Virus-neutralizing antibody (VNA) titers were determined by rapid fluorescent focus inhibition tests (RFFITs) and quantified using the World Health Organization (WHO) international units (IU/ml). Means and S.D. were calculated from four independent experiments. Significant difference is indicated (*: p < 0.05) in the neutralizing activities against HEP and HEP-30V in the H1 rabbit serum after application of two-way ANOVA followed by Tukey.